Stanford Blood Center Red Blood Cells and Pathogen Reduced Cryoprecipitated Fibrinogen Complex
Red blood cells and a fibrinogen complex were collected with potential air contamination.
Recall ended Sep 4, 2026. Still check yours.
Moderate risk
Taking it may cause temporary or medically reversible health problems. Serious harm is unlikely.
FDA Class II recall · How risk is rated
What happened
Stanford Blood Center LLC recalled Red Blood Cells, Leukocytes Reduced and Pathogen Reduced Cryoprecipitated Fibrinogen Complex because they were collected in a manner with a potential for air contamination and were distributed. The recall began March 2, 2026, and was added to the FDA's Enforcement Report on September 4, 2026.
Summary by Recall Canary from the FDA notice.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
2 products
Compare these product details with yours, then check the recall notice for any restrictions.
Pathogen Reduced Cryoprecipitated Fibrinogen Complex
Reason: Pathogen Reduced Cryoprecipitated Fibrinogen Complex, collected in a manner with a potential for air contamination, was distributed.
Red Blood Cells, Leukocytes Reduced
Reason: Red Blood Cells, Leukocytes Reduced, collected in a manner with a potential for air contamination, were distributed.
Details
- Company began the recall
- Event ID
- 99464
- Company
- Stanford Blood Center LLC
- Hazard
- Contamination
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
